CML develops when hematopoietic stem cells acquire a reciprocal translocation between chromosomes 9 and 22 that creates a fusion between the breakpoint cluster region (BCR) on chromosome 22 and the Abelson (ABL) tyrosine kinase on chromosome 9. Here, ABL1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.